Gynecologic Oncology News & Articles

281 Metformin and the risk of endometrial cancer: A case-control analysis Gynecologic Oncology, March 25, 2013    Clinical Article

282 Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type Gynecologic Oncology, March 25, 2013    Clinical Article

283 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors Obstetrics and Gynecology, March 25, 2013    Clinical Guideline

284 The relationship between tumor size and stage in early versus advanced ovarian cancer Medical Hypotheses, March 25, 2013    Review Article

285 Taxane-sensitivity of ovarian carcinomas previously treated with paclitaxel and carboplatin Cancer Chemotherapy and Pharmacology, March 25, 2013    Clinical Article

286 Undifferentiated Endometrial Carcinoma: A Diagnosis Frequently Overlooked Full Text Archives of Pathology & Laboratory Medicine, March 25, 2013    Review Article

287 Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer Gynecologic Oncology, March 25, 2013    Clinical Article

288 Implementing specificity of HPV-DNA primary screening in a successful organised cervical cancer prevention programme Gynecologic Oncology, March 25, 2013    Review Article    Clinical Article

289 A clinicopathological and immunohistochemical study of minimal deviation adenocarcinoma of the uterine cervix Medical Hypotheses, March 25, 2013    Clinical Article

290 Conservative treatment for complex neonatal ovarian cysts: A long-term follow-up analysis Journal of Pediatric Surgery, March 25, 2013    Clinical Article

291 Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma European Journal of Obstetrics & Gynecology and Reproductive Biology, March 22, 2013    Clinical Article

292 The endoplasmic reticulum stress marker, glucose-regulated protein-78 (GRP78) in visceral adipocytes predicts endometrial cancer progression and patient survival Gynecologic Oncology, March 22, 2013    Clinical Article

293 Upfront Treatment of Locally Advanced Cervical Cancer with Intensity Modulated Radiation Therapy Compared to Four-Field Radiation Therapy: A Cost-Effectiveness Analysis Gynecologic Oncology, March 22, 2013    Clinical Article

294 HPV-16 E6 and E7 protein T cell epitopes prediction analysis based on distributions of HLA-A loci across populations: An in silico approach Vaccine , March 22, 2013    Review Article

295 Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer Cancer Gene Therapy, March 22, 2013    Clinical Article

296 Chinese women's motivation to receive future screening: The role of social-demographic factors, knowledge and risk perception of cervical cancer European Journal of Oncology Nursing , March 22, 2013    Clinical Article

297 Acute phlegmonous esophagitis as a rare but threatening complication of chemoradiotherapy: report of a case Surgery Today, March 22, 2013

298 A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix International Journal of Clinical Oncology, March 21, 2013    Clinical Article

299 Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis Full Text BMC Cancer, March 21, 2013    Clinical Article

300 Validated gene targets associated with curatively treated advanced serous ovarian carcinoma Gynecologic Oncology, March 21, 2013    Clinical Article

1 Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions Cochrane Reviews, April 1, 2013    Review Article

2 Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere Gynecologic Oncology, April 9, 2013

3 Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group Study Gynecologic Oncology, April 18, 2013

4 Tubulin-beta-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones Cancer, April 22, 2013

5 Early detection of ovarian cancer American Journal of Obstetrics and Gynecology, April 18, 2013    Review Article

6 Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial The Lancet Oncology, March 14, 2013

7 High-grade vaginal intraepithelial neoplasia: can we be selective about who we treat? BJOG: An International Journal of Obstetrics and Gynaecology, April 4, 2013

8 Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--The Mimosa Study Journal of Clinical Oncology, March 15, 2013

9 The role of the fallopian tube in the origin of ovarian cancer American Journal of Obstetrics and Gynecology, April 18, 2013

10 Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer Gynecologic Oncology, April 26, 2013

11 Controversies of the Hormonal Conservative Treatment of Endometrial Cancer Gynecologic and Obstetric Investigation, April 1, 2013

12 An international assessment of ovarian cancer incidence and mortality Gynecologic Oncology, April 9, 2013

13 A Review of Dietary Prevention of Human Papillomavirus-Related Infection of the Cervix and Cervical Intraepithelial Neoplasia Nutrition and Cancer, April 1, 2013

14 Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts Archives of Gynecology and Obstetrics, April 10, 2013

15 Controversies of the Hormonal Conservative Treatment of Endometrial Cancer Gynecologic and Obstetric Investigation, April 12, 2013    Review Article

16 Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: Single institution experience Gynecologic Oncology, March 12, 2013

17 Fertility treatment and childhood cancer risk: A systematic meta-analysis Fertility and Sterility, April 8, 2013    Evidence Based Medicine    Review Article

18 Outcome of stage IB2-IIB patients with bulky uterine cervical cancer who underwent neoadjuvant chemotherapy followed by radical hysterectomy International Journal of Clinical Oncology, April 19, 2013

19 Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients Annals of Oncology, April 29, 2013

20 Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and amounts of extracellular microvesicles released from HPV-positive cancer cells International Journal of Cancer, April 1, 2013